- Home
- TBHC vs ZYXI Comparison
TBHC vs ZYXI Comparison
Compare TBHC & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBHC | ZYXI |
|---|---|---|
| Founded | 1966 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.4M | 35.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TBHC | ZYXI |
|---|---|---|
| Price | $1.18 | $0.67 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 117.9K | ★ 14.6M |
| Earning Date | 12-17-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $420,610,000.00 | $108,202,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.05 | $0.38 |
| 52 Week High | $2.40 | $8.72 |
Technical Indicators
Market Signals| Indicator | TBHC | ZYXI |
|---|---|---|
| Relative Strength Index (RSI) | 36.88 | 40.31 |
| Support Level | $1.18 | $0.75 |
| Resistance Level | $1.30 | $0.95 |
| Average True Range (ATR) | 0.07 | 0.28 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 24.18 | 0.74 |
Price Performance
Historical ComparisonAbout TBHC The Brand House Collective Inc.
The Brand House Collective Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.